Divi's Laboratories Limited (BOM:532488)

Divi's Laboratories Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	112,300	105,600	93,600	78,450	77,670	89,599
Revenue Growth	16.35%	12.82%	19.31%	1.00%	-13.31%	28.56%
Gross Profit Gross Profit Growth	68,770	62,370	54,250	44,860	44,930	57,938
Operating Income Operating Income Growth	34,900	29,780	25,700	18,310	20,260	35,726
Net Income Net Income Growth	29,250	25,680	21,910	16,000	18,240	29,605
Earnings Per Share EPS Growth	110.21	96.73	82.53	60.27	68.69	111.52
EPS Growth	26.95%	17.21%	36.93%	-12.26%	-38.41%	49.19%

Revenue by Geography

Chart

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Other Countries Other Countries Growth	56,980	50,390	47,890	42,580	59,173
USA USA Growth	10,920	13,060	10,470	18,470	20,047
Switzerland Switzerland Growth	26,110	19,080	10,250	6,860	-
India India Growth	11,590	11,070	9,840	9,760	10,378
Total Total Growth	105,600	93,600	78,450	77,670	89,598

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	32,330	32,330	35,270	36,980	41,330	27,417
Total Debt Total Debt Growth	70	70	40	30	40	36.9
Net Cash (Debt) Net Cash Growth	32,260	32,260	35,230	36,950	41,290	27,380
Net Cash Growth	-8.43%	-8.43%	-4.66%	-10.51%	50.80%	31.89%
Net Cash Per Share Net Cash Per Share Growth	121.56	121.52	132.71	139.19	155.54	103.14

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	-	27,380	16,530	12,610	24,590	19,118
Capital Expenditures CapEx Growth	-	-25,200	-14,380	-10,030	-4,730	-7,132
Free Cash Flow Free Cash Flow Growth	-	2,180	2,150	2,580	19,860	11,986
Free Cash Flow Growth	-	1.40%	-16.67%	-87.01%	65.69%	15.61%

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	61.24%	59.06%	57.96%	57.18%	57.85%	64.66%
Operating Margin	31.08%	28.20%	27.46%	23.34%	26.09%	39.87%
Pretax Margin	34.15%	32.08%	31.15%	27.57%	30.50%	41.11%
Profit Margin	26.05%	24.32%	23.41%	20.39%	23.48%	33.04%
FCF Margin	-	2.06%	2.30%	3.29%	25.57%	13.38%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 2, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Dividend Per Share Dividend Per Share Growth	30.000	30.000	30.000	30.000	30.000	30.000
Dividend Per Share Growth	0%	0%	0%	0%	0%	50.00%
Dividend Yield	0.38%	0.51%	0.52%	0.89%	1.09%	0.70%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 2, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	73.12	61.48	69.98	57.16	41.09	39.47
P/FCF Ratio	981.02	724.19	713.12	354.50	37.74	97.50
PS Ratio	19.04	14.95	16.38	11.66	9.65	13.04

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 2, 2026

Data Sources Report a data error